Minimizing endogenous cryptic plasmids to construct antibiotic-free expression systems for Escherichia coli Nissle 1917

Minimizing endogenous cryptic plasmids to construct antibiotic-free expression systems for Escherichia coli Nissle 1917

The probiotic bacterium Escherichia coli Nissle 1917 (EcN) holds significant promise for use in clinical and biological industries. However, the reliance on antibiotics to maintain plasmid-borne genes has overshadowed its benefits. In this study, we addressed this issue by engineering the endogenous...

Full description

Bibliographic Details
Main Authors:	Siyan Zhou, Linlin Zhao, Wenjie Zuo, Yilin Zheng, Ping Zhang, Yanan Sun, Yang Wang, Guocheng Du, Zhen Kang
Format:	Article
Language:	English
Published:	KeAi Communications Co., Ltd. 2024-03-01
Series:	Synthetic and Systems Biotechnology
Subjects:	Cryptic plasmids Antibiotic-free Gene expression Plasmid stability E. coli Nissle 1917
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405805X24000061

Similar Items

Probiyotik Escherichia coli Suşu Nissle 1917
by: Seda Altuntaş, et al.
Published: (2017-12-01)

Probiyotik Escherichia coli Suşu Nissle 1917
by: Seda ALTUNTAŞ, et al.
Published: (2017-12-01)

Probiyotik Escherichia coli Suşu Nissle 1917
by: Seda Altuntaş, et al.
Published: (2017-12-01)

Probiyotik Escherichia coli Suşu Nissle 1917
by: Seda Altuntaş, et al.
Published: (2017-12-01)

Inhibitory Effect of E. coli Nissle 1917 on Clinical and Standard Strains of Pseudomonas aeruginosa
by: Sheyda Damoogh, et al.
Published: (2021-01-01)

Transcriptional Profiling of the Probiotic <i>Escherichia coli</i> Nissle 1917 Strain under Simulated Microgravity
by: Jaewoo Yim, et al.
Published: (2020-04-01)

A comparative study on the genomes, transcriptomes, and metabolic properties of Escherichia coli strains Nissle 1917, BL21(DE3), and MG1655
by: Linlin Zhao, et al.
Published: (2022-03-01)

Advances in Escherichia coli Nissle 1917 as a customizable drug delivery system for disease treatment and diagnosis strategies
by: Haojie Chen, et al.
Published: (2023-02-01)

Wild-type Escherichia coli Nissle 1917 improves hyperuricemia by anaerobically degrading uric acid and maintaining gut microbiota profile of mice
by: Yanmei Sun, et al.
Published: (2024-01-01)

Neuroprotective effects of an engineered Escherichia coli Nissle 1917 on Parkinson's disease in mice by delivering GLP‐1 and modulating gut microbiota
by: Heng Wu, et al.
Published: (2023-09-01)

Antibacterial MccM as the Major Microcin in <i>Escherichia coli</i> Nissle 1917 against Pathogenic Enterobacteria
by: Yi Ma, et al.
Published: (2023-07-01)

Severity of Experimental Autoimmune Uveitis Is Reduced by Pretreatment with Live Probiotic <i>Escherichia coli</i> Nissle 1917
by: Otakar Dusek, et al.
Published: (2020-12-01)

Probiotic Escherichia coli Nissle 1917-derived outer membrane vesicles modulate the intestinal microbiome and host gut-liver metabolome in obese and diabetic mice
by: Jun Shi, et al.
Published: (2023-08-01)

Development of a Genome-Scale Metabolic Model and Phenome Analysis of the Probiotic <i>Escherichia coli</i> Strain Nissle 1917
by: Dohyeon Kim, et al.
Published: (2021-02-01)

<i>Escherichia</i><i>coli</i> Nissle 1917 as a Novel Microrobot for Tumor-Targeted Imaging and Therapy
by: Qingyao Liu, et al.
Published: (2021-08-01)

Deciphering the Crucial Roles of the Quorum-Sensing Transcription Factor SdiA in NADPH Metabolism and (<i>S</i>)-Equol Production in <i>Escherichia coli</i> Nissle 1917
by: Zhe Wang, et al.
Published: (2024-02-01)

The Combined Escherichia coli Nissle 1917 and Tryptophan Treatment Modulates Immune and Metabolome Responses to Human Rotavirus Infection in a Human Infant Fecal Microbiota-Transplanted Malnourished Gnotobiotic Pig Model
by: Husheem Michael, et al.
Published: (2022-10-01)

<i>Escherichia coli</i> Nissle 1917 Antagonizes <i>Candida albicans</i> Growth and Protects Intestinal Cells from <i>C. albicans</i>-Mediated Damage
by: Yasmine Rebai, et al.
Published: (2023-07-01)

High-quality genome-scale metabolic network reconstruction of probiotic bacterium Escherichia coli Nissle 1917
by: Max van ‘t Hof, et al.
Published: (2022-12-01)

The mercuric and organomercurial detoxifying enzymes from a plasmid-bearing strain of escherichia coli /
by: 353212 Schottel, Janet L.

Tumor Colonization and Therapy by <i>Escherichia coli</i> Nissle 1917 Strain in Syngeneic Tumor-Bearing Mice Is Strongly Affected by the Gut Microbiome
by: Ivaylo Gentschev, et al.
Published: (2022-12-01)

E. coli Nissle 1917 ameliorates mitochondrial injury of granulosa cells in polycystic ovary syndrome through promoting gut immune factor IL-22 via gut microbiota and microbial metabolism
by: Man Luo, et al.
Published: (2023-05-01)

Beyond the ABCs—Discovery of Three New Plasmid Types in <i>Rhodobacterales</i> (RepQ, RepY, RepW)
by: Heike M. Freese, et al.
Published: (2022-03-01)

Complete genome sequence and antimicrobial resistance analysis of ESBL-producing Shigella sonnei carrying small cryptic plasmids isolated in northern Italy
by: Stefano Amadesi, et al.
Published: (2023-06-01)

Plasmid-mediated fosfomycin resistance in Escherichia coli isolates of worldwide origin
by: Jacqueline Findlay, et al.
Published: (2023-12-01)

Probiotic Escherichia coli Nissle 1917 protect chicks from damage caused by Salmonella enterica serovar Enteritidis colonization
by: Shu Wu, et al.
Published: (2023-09-01)

Supplementation of Labneh with Passion Fruit Peel Enhanced Survival of <i>E. coli</i> Nissle 1917 during Simulated Gastrointestinal Digestion and Adhesion to Caco-2 Cells
by: Mohamed Samir Darwish, et al.
Published: (2022-06-01)

Expression of a plasmid-encoded gene for cadmium resistance of pseudomonus /
by: 214649 Keichi Kawai

Plasmids : genetics, applications and health /
by: Gonzales, Favian E. Rivera, et al.
Published: (2012)

Active partitioning of bacterial plasmids /
by: 434488 Williams, D. Ross, et al.

Methods for isolating large bacterial plasmids/
by: 429583 Gowland, P. C., et al.

Multidrug resistance plasmids commonly reprogram the expression of metabolic genes in Escherichia coli
by: Rebecca J. Hall, et al.
Published: (2024-03-01)

Comprehensive probiogenomics analysis of the commensal Escherichia coli CEC15 as a potential probiotic strain
by: Tales Fernando da Silva, et al.
Published: (2023-11-01)

Plasmid Curing in Multi-Drug Resistant Hospital and Community Uropathogenic <i>Escherichia coli</i>
by: DJ Onyeadi, et al.
Published: (2019-02-01)

Plasmid Profiling and Antibiotic Resistance of Escherichia Coli and Escherichia Coli O157 Strains
by: Abd. Mutalib, Sahilah
Published: (1997)

Curing of pBR322 and pBR329 plasmids in Escherichia coli by cis-dichlorodiamine platinum (II) chloride (Cis-DDP) /
by: 453926 Lakshmi, V. V., et al.

Emerging Opportunity and Destiny of mcr-1- and tet(X4)-Coharboring Plasmids in Escherichia coli
by: Xiaoyu Lu, et al.
Published: (2021-12-01)

Additive effect of probiotics (Mutaflor) on 5-aminosalicylic acid therapy in patients with ulcerative colitis
by: Soo-Kyung Park, et al.
Published: (2022-09-01)

Application of Plasmid Engineering to Enhance Yield and Quality of Plasmid for Vaccine and Gene Therapy
by: Olusegun Folarin, et al.
Published: (2019-06-01)

Frequency of Plasmid-mediated Quinolone Resistance Genes in Extended-spectum β-lactamase-producing Escherichia coli
by: Alisha Akya, et al.
Published: (2017-08-01)